Click here to discover the largest collection of GeneMedi's Promise-ORF™ ORF/cDNA expression clones
- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected]
Protocol Library Download
 |
 |
Human CXCR7/GPR159/RDC1 ORF/cDNA clone-Adenovirus particle (BC036661)
Cat. No.: vGMAP000125
Pre-made Human CXCR7/GPR159/RDC1 Adenovirus for CXCR7 overexpression in-vitro and in-vivo. The CXCR7 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified CXCR7-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
CXCR7/ACKR3/CXCR7/GPR159 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
MSDS
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP000125 | Human CXCR7 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP000125 |
| Gene Name | CXCR7 |
| Accession Number | BC036661 |
| Gene ID | 57007 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 1089 bp |
| Gene Alias | GPR159,RDC1 |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Kanamycin |
| ORF Nucleotide Sequence | ATGGATCTGCATCTCTTCGACTACTCAGAGCCAGGGAACTTCTCGGACATCAGCTGGCCATGCAACAGCAGCGACTGCATCGTGGTGGACACGGTGATGTGTCCCAACATGCCCAACAAAAGCGTCCTGCTCTACACGCTCTCCTTCATTTACATTTTCATCTTCGTCATCGGCATGATTGCCAACTCCGTGGTGGTCTGGGTGAATATCCAGGCCAAGACCACAGGCTATGACACGCACTGCTACATCTTGAACCTGGCCATTGCCGACCTGTGGGTTGTCCTCACCATCCCAGTCTGGGTGGTCAGTCTCGTGCAGCACAACCAGTGGCCCATGGGCGAGCTCACGTGCAAAGTCACACACCTCATCTTCTCCATCAACCTCTTCGGCAGCATTTTCTTCCTCACGTGCATGAGCGTGGACCGCTACCTCTCCATCACCTACTTCACCAACACCCCCAGCAGCAGGAAGAAGATGGTACGCCGTGTCGTCTGCATCCTGGTGTGGCTGCTGGCCTTCTGCGTGTCTCTGCCTGACACCTACTACCTGAAGACCGTCACGTCTGCGTCCAACAATGAGACCTACTGCCGGTCCTTCTACCCCGAGCACAGCATCAAGGAGTGGCTGATCGGCATGGAGCTGGTCTCCGTTGTCTTGGGCTTTGCCGTTCCCTTCTCCATTGTCGCTGTCTTCTACTTCCTGCTGGCCAGAGCCATCTCGGCGTCCAGTGACCAGGAGAAGCACAGCAGCCGGAAGATCATCTTCTCCTACGTGGTGGTCTTCCTTGTCTGCTGGTTGCCCTACCACGTGGCGGTGCTGCTGGACATCTTCTCCATCCTGCACTACATCCCTTTCACCTGCCGGCTGGAGCACGCCCTCTTCACGGCCCTGCATGTCACACAGTGCCTGTCGCTGGTGCACTGCTGCGTCAACCCTGTCCTCTACAGCTTCATCAATCGCAACTACAGGTACGAGCTGATGAAGGCCTTCATCTTCAAGTACTCGGCCAAAACAGGGCTCACCAAGCTCATCGATGCCTCCAGAGTCTCAGAGACGGAGTACTCTGCCTTGGAGCAGAGCACCAAATGA |
| ORF Protein Sequence | MDLHLFDYSEPGNFSDISWPCNSSDCIVVDTVMCPNMPNKSVLLYTLSFIYIFIFVIGMIANSVVVWVNIQAKTTGYDTHCYILNLAIADLWVVLTIPVWVVSLVQHNQWPMGELTCKVTHLIFSINLFGSIFFLTCMSVDRYLSITYFTNTPSSRKKMVRRVVCILVWLLAFCVSLPDTYYLKTVTSASNNETYCRSFYPEHSIKEWLIGMELVSVVLGFAVPFSIVAVFYFLLARAISASSDQEKHSSRKIIFSYVVVFLVCWLPYHVAVLLDIFSILHYIPFTCRLEHALFTALHVTQCLSLVHCCVNPVLYSFINRNYRYELMKAFIFKYSAKTGLTKLIDASRVSETEYSALEQSTK |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T10491-Ab | Anti-ACKR3/ CMKOR1/ CXC-R7 monoclonal antibody |
| Target Antigen | GM-Tg-g-T10491-Ag | ACKR3 VLP (virus-like particle) |
| Cytokine | cks-Tg-g-GM-T10491 | chemokine (C-X-C motif) receptor 7 (CXCR7) protein & antibody |
| ORF Viral Vector | pGMLP003139 | Human ACKR3 Lentivirus plasmid |
| ORF Viral Vector | pGMLV000082 | Human ACKR3 Lentivirus plasmid |
| ORF Viral Vector | pGMLV000566 | Human ACKR3 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000125 | Human CXCR7 Adenovirus plasmid |
| ORF Viral Vector | pGMAP000127 | Human CXCR7 Adenovirus plasmid |
| ORF Viral Vector | vGMLP003139 | Human ACKR3 Lentivirus particle |
| ORF Viral Vector | vGMLV000082 | Human ACKR3 Lentivirus particle |
| ORF Viral Vector | vGMLV000566 | Human ACKR3 Lentivirus particle |
| ORF Viral Vector | vGMAP000125 | Human CXCR7 Adenovirus particle |
| ORF Viral Vector | vGMAP000127 | Human CXCR7 Adenovirus particle |
Target information
| Target ID | GM-T10491 |
| Target Name | CXCR7/ACKR3 |
|
Gene Group Identifier （Target Gene ID in Homo species) |
57007 |
| Gene ID |
100057501 (Equus caballus), 101080817 (Felis catus), 12778 (Mus musculus), 403964 (Canis lupus familiaris) 509585 (Bos taurus), 57007 (Homo sapiens), 694428 (Macaca mulatta), 84348 (Rattus norvegicus) |
| Gene Symbols & Synonyms | ACKR3,Ackr3,CXCR7,Rdc1,Cxcr7,RDC-1,CXC-R7,CXCR-7,Cmkor1,RDC1,CMKOR1,GPR159 |
| Target Alternative Names | ACKR3,Ackr3,Atypical chemokine receptor 3,C-X-C chemokine receptor type 7 (CXC-R7,CMKOR1,CXC-R7,CXCR-7,CXCR-7),CXCR7,Chemokine orphan receptor 1,Cmkor1,Cxcr7,G-protein coupled receptor 159,G-protein coupled receptor RDC1 homolog (RDC-1),GPR159,RDC-1,RDC1,Rdc1 |
| Uniprot Accession |
O89039,P11613,P25106,P56485
Additional SwissProt Accessions: P56485,P11613,P25106,O89039 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target, Cytokine Target |
| Disease | cancer |
| Disease from KEGG | Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor |
| Gene Ensembl | ENSECAG00000000942, ENSMUSG00000044337, ENSCAFG00845027671, ENSBTAG00000018424, ENSG00000144476, ENSMMUG00000060487 |
| Target Classification | GPCR, Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA) |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.